arrow
A

Anja Oštrbenk Valenčak

university of ljubljana
H指数:15
被引数:649
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2)

甲基化标志物<i>FAM19A4/mir124-2</i>和HPV基因型在宫颈上皮内瘤变2级(CIN2)女性主动监测中的作用

2026-10-280
PRE
International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening

国际合作研究:人乳头瘤病毒分析阈值在宫颈癌筛查中的敏感性和特异性

2026-04-250
OAAI
FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years

30岁以下HPV阳性女性的FAM19A4/miR124-2甲基化检测和人乳头瘤病毒 (HPV) 16/18基因分型

2022-06-1016
OAAI
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
2021-07-0112
OAAI
Classification of high-grade cervical intraepithelial neoplasia by p16ink4a, Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management

通过p16ink4a,HPV,Ki-67,HPV E4和FAM19A4/miR124-2甲基化状态对高级别宫颈上皮内瘤变进行分类显示出相当大的异质性,对管理有潜在的影响

2021-05-1132
OAAI
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries
2021-04-0115
OAAI
Methylation markersFAM19A4andmiR124-2as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

原发性人乳头瘤病毒筛查阳性妇女的甲基化markersFAM19A4andmiR124-2as分诊策略: 一项大型欧洲多中心研究

2020-10-2180
OAAI